Newsletter Subject

IL-17 inhibitor Secukinumab Found Effective in Mild-to-Moderate Psoriasis

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Apr 14, 2023 10:52 PM

Email Preheader Text

Daily Headlines Friday, April 14, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Friday, April 14, 2023 Today's Top Stories for {NAME} [AAD READING ROOM]( [IL-17 inhibitor Secukinumab Found Effective in Mild-to-Moderate Psoriasis]( [ONCOLOGY/HEMATOLOGY]( [Precancerous Lesions in Donor Organs; Dire Cancer Drug Shortage; CVD Ups Cancer Risk]( [PUBLIC HEALTH & POLICY]( [Texas Mifepristone Case Could Lead to Other Drug Approval Lawsuits, Experts Say]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Harnessing the Potential of Novel Therapies in Multiple Myeloma]( [OPINION]( [The Evolution of Opioid Addiction Care]( [ACR READING ROOM]( [Patients With Inflammatory Arthritis Confused About Vaccine Recommendations]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Renal Function Safe With Pegloticase-MTX Combo for Gout]( CME SPOTLIGHT [Novel Immunotherapeutic Approaches in Relapsed/Refractory Multiple Myeloma]( [OPINION]( [We're Treating Low Back Pain All Wrong]( [ONCOLOGY/HEMATOLOGY]( [Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrence]( [MEETING COVERAGE]( [Low-Potassium Diet Not Enough to Stave off Recurrent Hyperkalemia]( CME SPOTLIGHT [Differentiating Established and Novel Treatment Approaches for TNBC Based on Mechanism of Action, Safety, Efficacy, and Approved Indications]( [NEUROLOGY]( [SARS-CoV-2 Spike Protein Accumulates in the Skull and Brain]( [ACR READING ROOM]( [We Know Too Little About Vaccines in Patients With Inflammatory Diseases]( [PSYCHIATRY]( [FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( [SPECIAL REPORTS]( [AAMC Warns of Possible Physician Shortage in States That Ban Abortion]( [CARDIOLOGY]( [Stepwise Catheter Ablation Named Winner for Persistent Afib]( [INFECTIOUS DISEASE]( [FDA Panel to Weigh Limited Data on Combo for Healthcare-Acquired Pneumonia]( CME SPOTLIGHT [Advancing Care of Patients With Sickle Cell Disease]( CME SPOTLIGHT [Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams]( # Weekly Survey [Judges' Personal Views Influence Legal Decisions?]( A federal judge in Texas overturned [the approval of mifepristone](, calling the FDA's 2000 decision to approve the abortion drug 'unsound'; an appeals court [partly overruled the decision](, leaving in place some restrictions on the drug's use[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-04-14&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.